Hormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptors

British Journal of Cancer

Volumn 84, Issue 7, 2001, Pages 881-885

  Villa, E ^a   Ferretti, I ^a   Grottola, A ^a   Buttafoco, P ^a   Buono, M Grazia Del ^a   Giannini, F ^a   Manno, M ^a   Bertani, H ^a   Dugani, A ^a   Manenti, F ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Hepatocellular carcinoma; Megestrol; Tamoxifen; Variant liver oestrogen receptors transcripts

Indexed keywords

BILIRUBIN; ESTROGEN RECEPTOR; MEGESTROL; PLACEBO;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS B VIRUS; HUMAN; INOPERABLE CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME; TUMOR GROWTH; VAGINA BLEEDING;

ALTERNATIVE SPLICING; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MEGESTROL; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE;

EID: 17744383359     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1534     Document Type: Article

References (21)

1. Treatment of small hepatocellular carcinoma in cirrhotic patients: A cohort study comparing surgical resection and percutaneous ethanol injection
2. Treatment of hepatocellular carcinoma with tamoxifen: A double-blind trial in 120 patients
3. Phase II study of megestrol acetate in the treatment of hepatocellular carcinoma
4. Regression models and life tables (with discussion)
5. Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma
6. A Phase II trial in hepatocellular carcinoma
7. Unresectable hepatocellular carcinoma. A prospective controlled trial with tamoxifen
8. Variant human breast tumor estrogen receptor with constitutive transcriptional activity
9. Tamoxifen in the treatment of hepatocellular carcinoma: A randomised controlled trial
10. Non-parametric estimation for incomplete observation
11. Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma
12. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
13. Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials
14. Tumor size determines the efficacy of percutaneous ethanol injection for treatment of small hepatocellular carcinoma
15. Risk factors for hepatocellular carcinoma in Italy: HBV virus, alcohol, male sex
16. Variant estrogen receptor messenger RNA species detected in human primary hepatocellular carcinoma
17. Variant liver estrogen receptors and response to tamoxifen
18. Type of estrogen receptor determines response to antiestrogen therapy in hepatocellular carcinoma
19. Survival of patients with hepatocellular carcinoma is determined by type of liver estrogen receptors
20. Variant liver estrogen receptor transcripts already occur at an early stage of chronic liver disease
21. Risk factors in development of hepatocellular carcinoma in cirrhosis: Prospective study of 613 patients